Every material Form 8-K DELCATH SYSTEMS, INC. has filed with the SEC since May 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Delcath Systems reported third-quarter 2026 revenue of $35.1 million, up from $20.6 million a year earlier, and net income of $7.0 million, compared with $0.8 million. The company raised its full-year 2026 revenue guidance to $115 million to $117 million, which signals continued growth in HEPZATO KIT sales for shareholders.
Q3 2026 net income of $7.0 million, or $0.17 diluted per share, versus $0.8 million, or $0.02 per share, in Q3 2025
Q3 2026 HEPZATO KIT revenue of $32.7 million, up from $19.3 million; non-GAAP adjusted EBITDA of $11.5 million, up from $5.3 million
2026 guidance raised to $115 million to $117 million in total revenue, with gross margins of 87% to 89% and positive adjusted EBITDA
Cash and investments of $104.3 million as of September 30, 2026, with no debt
Delcath Systems reported second-quarter 2026 total revenue of $29.1 million, up from $24.2 million a year earlier, and raised its full-year 2026 revenue guidance to $104 million to $108 million. Net income was $2.7 million in both quarters, while non-GAAP adjusted EBITDA fell to $7.6 million from $9.8 million, so shareholders get stronger sales alongside flat profit and lower adjusted EBITDA.
Q2 2026 total revenue was $29.1 million versus $24.2 million in Q2 2025; HEPZATO KIT revenue was $27.1 million.
Net income was $2.7 million in both Q2 2026 and Q2 2025; diluted income per share was $0.07 in both periods.
Non-GAAP adjusted EBITDA was $7.6 million versus $9.8 million a year earlier.
2026 revenue guidance was increased to $104 million to $108 million, with full-year gross margins expected at 86% to 89%; cash and investments were $95.9 million as of June 30, 2026.
At its annual meeting on May 13, 2026, Delcath Systems stockholders approved adding 1,800,000 shares to the 2020 Omnibus Equity Incentive Plan, which increases the shares available for equity awards. Stockholders also elected two Class II directors, ratified CBIZ CPAs P.C. as the independent auditor for 2026, and approved a non-binding advisory vote on executive compensation.
Equity plan amendment: 12,770,662 votes for, 2,322,773 against and 267,202 abstentions, with 1,800,000 additional shares authorized.
Elizabeth Czerepak (14,903,665 votes for) and John R. Sylvester (14,819,700 votes for) were elected as Class II directors, serving until the 2029 annual meeting.
Holders of 23,346,271 shares, about 67.44% of the 34,618,159 eligible shares, were present or represented at the meeting.
Executive compensation advisory vote: 13,244,653 votes for and 1,748,570 against.
Delcath Systems reported first-quarter 2026 total revenue of $25.0 million, up from $19.8 million a year earlier, driven by HEPZATO KIT sales of $23.3 million. The company swung to a net loss of $1.1 million from net income of $1.1 million, as research and development and SG&A expenses rose, and adjusted EBITDA fell to $3.4 million from $7.6 million. The company reaffirmed a 2026 outlook of at least $100 million in CHEMOSAT and HEPZATO KIT revenue, with positive adjusted EBITDA.
Total revenue of $25.0 million for the quarter ended March 31, 2026, versus $19.8 million a year earlier
Net loss of $1.1 million, compared with net income of $1.1 million in the first quarter of 2025
Adjusted EBITDA of $3.4 million, compared with $7.6 million; cash and investments of $89.3 million at March 31, 2026
2026 guidance: total CHEMOSAT and HEPZATO KIT revenue of at least $100 million and positive adjusted EBITDA
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DELCATH SYSTEMS, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →